Phase I study of optimal dose and pharmacokinetics of a Uracil/Tegafur (UFT) plus oral leucovorin regimen after liver resection for colorectal liver metastasis

ABSTRACT: Interventions: Oral administration of Tegaful/Uracil 200-300mg/m2/day and leucovorin 75mg/day for 5 course (5 weeks of administration followed by 1 week of no administration) Primary outcome(s): Optimal dose Study Design: Single arm Non-randomized

DISEASE(S): Liver Resection For Liver Metastasis Of Colorectal Cancer

PROVIDER: 2636415 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR